## Abstract Using an enzyme‐linked immunosorbant assay for antibody against hepatitis C virus (anti‐HCV), serial serum samples from 26 non‐A, non‐B (NANB) posttransfusion hepatitis (PTH) patients were studied in a prospective study in Taiwan. Sixteen (61.5%) of the 26 patients were positive for ant
Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan
✍ Scribed by Chyng-Wen Fwu; Yin-Chu Chien; San-Lin You; Kenrad E. Nelson; Gregory D. Kirk; Hsu-Sung Kuo; Manning Feinleib; Chien-Jen Chen
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 217 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Some individuals who are chronically infected with hepatitis B virus (HBV) eventually lose hepatitis B surface antigen (HBsAg). Hepatocellular carcinoma (HCC) has been demonstrated to occur in a few patients after loss of HBsAg. Neither factors associated with loss of HBsAg nor the incidence of HCC
## Abstract ## BACKGROUND. The authors investigated the prevalence of hepatitis B virus (HBV) infection by using serologic markers in non‐Hodgkin lymphoma (NHL) compared with other types of cancers in Chinese patients. ## METHODS. In this case‐control study, HBV and other hepatitis markers were
## Abstract Several studies have noted elevated hepatitis C virus (HCV) prevalence among patients with non‐Hodgkin lymphoma (NHL), suggesting that HCV infection increases NHL risk through chronic immune stimulation. Population‐based data from the U.S. are lacking. In a population‐based case‐control
## Abstract Emerging data suggest that chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections may also play a role in extrahepatic bile duct cancers. To test the HBV hypothesis, we examined the relationship of HBV/HCV infection with risks of biliary tract cancer and biliary stones i